封面
市场调查报告书
商品编码
1571550

人工授精市场规模、份额、趋势分析报告:按类型、按来源、按最终用途、按地区、细分市场预测,2024-2030 年

Artificial Insemination Market Size, Share & Trends Analysis Report By Type (Intrauterine, Intracervical, Intravaginal, Intratubal), By Source Outlook, By End Use (AIH-Husband And AID-Donor), By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格
简介目录

人工授精市场成长与趋势:

Grand View Research, Inc.最新报告显示,预计到2030年,全球人工授精市场规模将达到40.1亿美元,2024年至2030年复合年增长率为8.6%。

近年来,不孕症已成为全球重大的公共卫生问题。人工授精通常是解决不孕症的第一线治疗方法。生活方式的改变、受孕延迟和荷尔蒙问题导致不孕症相关问题的增加。根据联合国预测,到2050年,全球出生率预计将下降至2.2%。在开发中国家和低度开发国家,有关不孕症的医疗咨询并不容易。

导致人们对人工授精、捐赠者人工授精、体外受精等辅助生殖技术缺乏认识。人工授精的平均费用约为865美元。每个週期的成功率为4-5%,使用促排卵药物可提高至7-16%。然而,不建议老年女性进行子宫腔内人工授精(IUI),因为成功的机会较低,并且可能会导致进一步的併发症。人工授精可以解决一些不孕问题,例如精液过敏、不明原因不孕和性行为感染传染病(STD)。

人工授精市场报告亮点

  • 2023 年宫内人工授精 (IUI) 占据市场主导地位,销售份额为 71.7%。这是因为其手术相对简单、侵入性极小并且能够有效治疗各种不孕问题。
  • AIH-Husband在2023年占了66.8%的销售份额。这是由于面临不孕症挑战的夫妻对辅助生殖技术的认识和接受程度不断提高。
  • 2023 年,生育诊所和其他机构以 53.2% 的份额主导市场。这些诊所提供受控环境,由经验丰富的医疗专业人员进行治疗,以最大限度地提高治疗效果。
  • 2023年亚太人工授精市场占30.1%份额。这一增长归因于不孕夫妇数量的增加和不孕不育治疗领域的技术进步。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章人工授精市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 人工授精市场分析工具
    • 波特的分析
    • PESTEL分析

第四章人工授精市场:依类型估价与趋势分析

  • 细分仪表板
  • 人工授精市场:2023 年和 2030 年按类型分類的波动分析
  • 子宫腔内人工授精
  • 子宫颈内人工授精
  • 阴道内人工授精
  • 输卵管内授精

第五章 人工授精市场:依来源估算与趋势分析

  • 细分仪表板
  • 人工授精市场:2023年及2030年依来源变化分析
  • 人工授精
  • 非配偶间的人工授精

第六章人工授精市场:最终用途的估计与趋势分析

  • 细分仪表板
  • 人工授精市场:2023 年和 2030 年最终用途的变化分析
  • 生育诊所和其他设施
  • 家用

第七章人工授精市场:依地区估价及趋势分析

  • 人工授精市场占有率:依地区划分,2023 年及 2030 年
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Vitrolife
    • Genea Pty Limited
    • Rinovum Women's Health, LLC
    • Pride Angel
    • HI-TECH SOLUTIONS
    • FUJIFILM Irvine Scientific
    • Kitazato Corporation
    • Rocket Medical plc
    • Conceivex, Inc.
简介目录
Product Code: GVR-2-68038-176-4

Artificial Insemination Market Growth & Trends:

The global artificial insemination market size is expected to reach USD 4.01 billion by 2030 registering a CAGR of 8.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Over the past few years, infertility has become a major public health concern across the globe. Artificial insemination is usually the preferred first-line treatment to tackle infertility. Lifestyle changes, delay in pregnancy, and hormonal issues are some of the reasons contributing to the rise in fertility-related problems. According to the United Nations, the global fertility rate is expected to decline to 2.2% by 2050. In developing or underdeveloped nations, medical consultation regarding infertility was not easily accessible.

Hence, there was a lack of awareness about available assisted reproductive techniques including artificial or donor insemination and IVF. The average cost of performing an IUI is around USD 865. The success rate for each cycle is around 4 to 5%, which can be increased to about 7 to 16% by consuming fertility drugs. However, older women are not encouraged to go through IUI due to slim chances of success and further complications. Several fertility problems can be addressed through IUI, such as semen allergy, unexplained infertility, and Sexually Transmitted Diseases (STDs).

Artificial Insemination Market Report Highlights:

  • Intrauterine insemination (IUI) dominated the market with 71.7% of revenue share in 2023. This is due to its relatively simple procedure, minimal invasiveness, and effectiveness in treating various infertility issues.
  • AIH-Husband dominated the market with 66.8% of revenue share in 2023. This is due to the increasing awareness and acceptance of assisted reproductive technologies among couples facing infertility challenges.
  • Fertility clinics & others dominated the market with 53.2% share in 2023. These clinics offer a controlled environment with experienced medical professionals to perform the procedure, maximizing its effectiveness.
  • Asia Pacific artificial insemination market dominated the market with 30.1% share in 2023. This growth is attributed to the rising number of infertile couples and technological advancements in the fertility segment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Artificial Insemination Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Artificial Insemination Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Artificial Insemination Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Artificial Insemination Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Intrauterine Insemination
    • 4.3.1. Intrauterine Insemination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Intracervical Insemination
    • 4.4.1. Intracervical Insemination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Intravaginal Insemination
    • 4.5.1. Intravaginal Insemination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Intratubal Insemination
    • 4.6.1. Intratubal Insemination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Artificial Insemination Market: Source Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Artificial Insemination Market: Source Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. AIH-Husband
    • 5.3.1. AIH-Husband Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. AID-Donor
    • 5.4.1. AID-Donor Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Artificial Insemination Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Artificial Insemination Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Fertility Clinics & Other Facilities
    • 6.3.1. Fertility clinics & other facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Home
    • 6.4.1. Home Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Artificial Insemination Market: Regional Estimates & Trend Analysis

  • 7.1. Artificial Insemination Market Share, By Region, 2023 & 2030, USD Million
  • 7.2. North America
    • 7.2.1. North America Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Vitrolife
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Genea Pty Limited
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Rinovum Women's Health, LLC
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Pride Angel
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. HI-TECH SOLUTIONS
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. FUJIFILM Irvine Scientific
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Kitazato Corporation
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Rocket Medical plc
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Conceivex, Inc.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives